Zymeworks Taps Royalty Pharma Executive Stafford as New CFO
Zymeworks appoints Royalty Pharma executive Kristin Stafford as CFO effective April 1, 2026, strengthening financial leadership amid pipeline advancement.
RPRXZYMEcapital allocationCFO appointment